Lotta et al. [18] conducted a Mendelian randomization study and found an association between ezetimibe exposure and elevated risk of type 2 diabetes, which was observed in individuals with genetic variants located near NPC1L1. This evidence concerns the gene NPC1L1 and type 2 diabetes mellitus.